{"id":2958,"date":"2016-10-04T18:57:30","date_gmt":"2016-10-04T18:57:30","guid":{"rendered":"http:\/\/www.medicalmarijuanainc.com\/?p=17812"},"modified":"2016-10-04T18:57:30","modified_gmt":"2016-10-04T18:57:30","slug":"hempmeds-mexico-host-first-national-symposium-benefits-cbd","status":"publish","type":"post","link":"https:\/\/medicalmarijuanainc.com\/2016\/10\/04\/hempmeds-mexico-host-first-national-symposium-benefits-cbd\/","title":{"rendered":"HempMeds\u00ae Mexico to Host Its First National Symposium on the Benefits of CBD"},"content":{"rendered":"

HempMeds\u00ae and their local branch HempMeds\u00ae Mexico are excited to invite doctors and health officials to our educational forum <\/span>Cannabidiol, Medical and Therapeutic Uses<\/span><\/i> on October 8, 2016, in col. Juarez, Mexico, at the Hotel Fiesta Americana Reforma.<\/span><\/p>\n

\u201cOne of our objectives [for this event] is to share with health professionals the results of international clinical studies that focus on the neuroprotective properties of cannabinoids, as well as several clinical applications,\u201d said Dion Markgraaff, President of HempMeds\u00ae Mexico.<\/span><\/p>\n

Cannabidiol, Medical and Therapeutic Uses<\/span><\/i> presents a unique educational opportunity for the doctors of Mexico to learn about cannabidiol and their ability to prescribe RSHO-X\u2122 to their patients now for certain intractable conditions.<\/span><\/p>\n

Not only is HempMeds\u00ae Mexico the event host, but Dr. Stuart Titus, CEO of HempMeds\u00ae parent company Medical Marijuana, Inc., will lead a presentation that will focus on HempMeds\u00ae\u2019s RSHO-X\u2122, the only legal cannabinoid-based product approved in Mexico. \u00a0Dr. Titus will also discuss the company\u2019s other ventures in making CBD hemp oil widely available in Latin America and beyond, the unrivaled quality of HempMeds\u00ae products, and the related history of Medical Marijuana, Inc.\u2019s other portfolio companies, including HempMeds\u00ae Brasil. <\/span><\/p>\n

Dr. Titus and the rest of the event\u2019s presenters will educate doctors on the many benefits of cannabinoids, specifically CBD, and provide training for them to \u00a0prescribe RSHO-X\u2122 now for their patients by discussing the process.<\/span><\/p>\n

\u201cOur products have been the first to be approved by regulatory health agencies in Mexico and elsewhere in Latin America, and we are now proud to be the first Company to establish rapprochement programs for the medical community.\u201d said Dr. Titus. \u201cWe are dedicated to actively educating health professionals on the plethora of benefits that cannabidiol from hemp provides to treat several types of indications.\u201d<\/span><\/p>\n

This event, in addition to educating participants on CBD use and laws in Mexico, will act as a fundraiser for the Por Grace Foundation. The Por Grace Foundation is a non-profit started by Raul Elizalde, father of Grace, who was diagnosed at a young age with a form of intractable childhood epilepsy, Lennox-Gastaut syndrome, and became the first patient in Mexico to legally import CBD. In conjunction with HempMeds\u00ae Mexico, Raul and the Por Grace Foundation have worked tirelessly to bring access to CBD to the people of Mexico, hosting public forums about medical cannabis and meeting with government officials in Mexico to lobby for expanded access to CBD. Learn more about the Por Grace Foundation and their efforts at <\/span>their website<\/span><\/a> and <\/span>Facebook page<\/span><\/a>.<\/span><\/p>\n

Also scheduled to speak are Dr. Saul Garza, Grace\u2019s Pediatric Neurologist, Dr. Jahan Marcu, a court certified expert on cannabis and synthetic cannabinoids, and Dr. George Anastassov, CEO of Medical Marijuana, Inc. portfolio company AXIM Biotechnologies.<\/span><\/p>\n

This historic symposium is one of the most important events on health and cannabis to take place in Mexico, and we urge doctors in the country not to miss this opportunity to educate themselves on the positive effects that cannabidiol can have on the lives of their patients.<\/span><\/p>\n